New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
19:17 EDTNBSNeoStem says no new securities issued in previous filing
NeoStem is clarifying that it is not engaged in a new financing. The registration statement filed earlier is a renewal of an outstanding registration statement covering the issuance of shares underlying warrants that were issued in 2011 and 2012 and remain outstanding. The underlying shares were previously registered, but the registration statement is expiring under SEC rules and needs to be refreshed. No new securities are being offered by NeoStem.
News For NBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
07:33 EDTNBSNeoStem receives drug manufacture license for Irvine, CA facility
NeoStem announced that the State of California's Department of Public Health, Food and Drug Branch has completed its review of NeoStem's manufacturing and control processes at its Irvine, California cGMP facility for the production of eltrapuldencel-T and has issued NeoStem a manufacturing license permitting NeoStem to manufacture drugs from this facility, including the manufacture of eltrapuldencel-T for clinical trial use. Eltrapuldencel-T is the company's patient-specific targeted cancer immunotherapy under investigation for the treatment of Stage IV or recurrent Stage III metastatic melanoma.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use